Search research articles
Contact Us
Filters
Showing results (121-130 of 144) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 9, 2024
Menin Inhibition With Revumenib for <i>KMT2A</i>-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, et al.
Blood Advances
|
January 4, 2018
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib
Cecelia R Miller, Amy S Ruppert, Nyla A Heerema, et al.
Blood
|
July 12, 2019
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia
Brian Giacopelli, Qiuhong Zhao, Amy S Ruppert, et al.
Blood Advances
|
July 5, 2022
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
Karilyn T Larkin, Deedra Nicolet, Benjamin J Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2017
BTK<sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia
Jennifer A Woyach, Amy S Ruppert, Daphne Guinn, et al.
Blood Cancer Discovery
|
November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Blood
|
January 12, 2024
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL
Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, et al.
The New England Journal of Medicine
|
December 4, 2018
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
Jennifer A Woyach, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia
|
June 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia
Darren Lee, Yazan Abu-Shihab, Kate Plas, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Prognostic and Therapeutic Implications of <i>BRAF</i> Mutations in Acute Myeloid Leukemia
Darren Lee, Yazan Abu-Shihab, Kate Plas, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 144) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 9, 2024
Menin Inhibition With Revumenib for <i>KMT2A</i>-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, et al.
Blood Advances
|
January 4, 2018
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib
Cecelia R Miller, Amy S Ruppert, Nyla A Heerema, et al.
Blood
|
July 12, 2019
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia
Brian Giacopelli, Qiuhong Zhao, Amy S Ruppert, et al.
Blood Advances
|
July 5, 2022
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
Karilyn T Larkin, Deedra Nicolet, Benjamin J Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2017
BTK<sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia
Jennifer A Woyach, Amy S Ruppert, Daphne Guinn, et al.
Blood Cancer Discovery
|
November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Blood
|
January 12, 2024
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL
Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, et al.
The New England Journal of Medicine
|
December 4, 2018
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
Jennifer A Woyach, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia
|
June 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia
Darren Lee, Yazan Abu-Shihab, Kate Plas, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Prognostic and Therapeutic Implications of <i>BRAF</i> Mutations in Acute Myeloid Leukemia
Darren Lee, Yazan Abu-Shihab, Kate Plas, et al.
Page
of 15